Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Cramo in connection with the acquisition of Tidermans
Mandate

Vinge advises Cramo in connection with the acquisition of Tidermans

June 29, 2011

Vinge has advised Cramo Sverige AB in conjunction with the acquisition of the entire issued share capital of Tidermans Hyrmaskiner AB and Tidermans Hyrmec AB (“Tidermans”). Tidermans is one of Western Sweden’s largest plant and machinery rental operations with four facilities in the Gothenburg region and one in Falkenberg. The company was founded in 1890 and for the last 60 years has focused exclusively on plant and machinery rental.

Vinge’s team consisted of responsible partner Johan Göthberg and associates Joacim Rydegård and Louise Markgren.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026